NZOZ Medica

At NZOZ Medica in Lublin, clinical research is focused on nutritional and metabolic diseases and metabolism, with a strong emphasis on Type 1 diabetes mellitus. These studies are exploring whether new treatment approaches can help preserve insulin production, improve blood sugar control, and support better long-term disease management.

• Evaluating a new therapy for recently diagnosed Type 1 diabetes
• Assessing whether treatment can help maintain beta cell function
• Investigating improved glycemic control in adolescents and adults

This area of research is centered on finding safer and more effective ways to slow disease progression and support early intervention in people living with diabetes.

Another key focus at the site is Type 2 diabetes mellitus, especially for patients whose blood sugar remains difficult to control. The trials are examining combination treatment strategies to improve everyday glucose management and strengthen the effectiveness of existing diabetes care.

• Testing add-on treatment options for Type 2 diabetes mellitus
• Studying ways to improve glycemic control when standard therapy is not enough
• Comparing combination approaches to support better treatment effectiveness

The research reflects a broader effort to refine metabolic disease treatment and identify combinations that may offer better control for people with persistent hyperglycemia.

Clinical trials at NZOZ Medica also address the connection between cardiovascular diseases and Type 2 diabetes mellitus. These studies are designed to determine whether diabetes therapies can also help reduce serious heart-related complications in patients with elevated cardiovascular risk.

• Studying treatment effects on major cardiovascular events
• Evaluating outcomes in patients with Type 2 diabetes and high heart risk
• Comparing therapies for both glucose management and cardiovascular protection

This line of research combines diabetes care with prevention of major heart and stroke events, highlighting the site’s interest in treatments that may support both metabolic and cardiovascular health.